Skip to content
healthcare.dev

ENALAPRIL MALEATE

NDC 50228-230, ENALAPRIL MALEATE, tablet, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-230
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075178
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-230 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ENALAPRIL MALEATE10 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Decreased Blood Pressure [PE]

Package NDCNDC-11Package
50228-230-0150228023001100 TABLET in 1 BOTTLE (50228-230-01)
50228-230-10502280230101000 TABLET in 1 BOTTLE (50228-230-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/63187a94-9ac7-4320-ac70-0631e08c2b8d
  • NADAC price for package 50228023001

    GET /v1/drugs/nadac/50228023001
  • NADAC price for package 50228023010

    GET /v1/drugs/nadac/50228023010

Use it

Look up 50228-230 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-230 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-230. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.